Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Crystal structure of a statin bound to a class II hydroxymethylglutaryl-CoA reductase.

Tabernero L, Rodwell VW, Stauffacher CV.

J Biol Chem. 2003 May 30;278(22):19933-8. Epub 2003 Mar 5.

2.

Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Istvan ES.

Am Heart J. 2002 Dec;144(6 Suppl):S27-32. Review.

PMID:
12486413
3.

Statin inhibition of HMG-CoA reductase: a 3-dimensional view.

Istvan E.

Atheroscler Suppl. 2003 Mar;4(1):3-8. Review.

PMID:
12714031
4.

Bacterial and mammalian HMG-CoA reductases: related enzymes with distinct architectures.

Istvan ES.

Curr Opin Struct Biol. 2001 Dec;11(6):746-51. Review.

PMID:
11751057
5.
6.

Statins and myotoxicity: a therapeutic limitation.

Tiwari A, Bansal V, Chugh A, Mookhtiar K.

Expert Opin Drug Saf. 2006 Sep;5(5):651-66. Review.

PMID:
16907655
7.

Statin safety and drug interactions: clinical implications.

Bottorff MB.

Am J Cardiol. 2006 Apr 17;97(8A):27C-31C. Epub 2006 Jan 25. Review.

PMID:
16581325
8.

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Tobert JA.

Nat Rev Drug Discov. 2003 Jul;2(7):517-26. Review.

PMID:
12815379
9.

Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin.

Holdgate GA, Ward WH, McTaggart F.

Biochem Soc Trans. 2003 Jun;31(Pt 3):528-31. Review.

PMID:
12773150
10.

Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.

Hrmova M, Fincher GB.

Carbohydr Res. 2007 Sep 3;342(12-13):1613-23. Epub 2007 May 18. Review.

PMID:
17548065
11.

Statin-induced rhabdomyolysis.

Schreiber DH, Anderson TR.

J Emerg Med. 2006 Aug;31(2):177-80. Review.

PMID:
17044581
12.
13.

Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.

Rosenson RS.

Expert Rev Cardiovasc Ther. 2003 Nov;1(4):495-505. Review.

PMID:
15030249
14.
15.

Lovastatin production: From molecular basis to industrial process optimization.

Mulder KC, Mulinari F, Franco OL, Soares MS, Magalhães BS, Parachin NS.

Biotechnol Adv. 2015 Nov 1;33(6 Pt 1):648-65. doi: 10.1016/j.biotechadv.2015.04.001. Epub 2015 Apr 11. Review.

PMID:
25868803
16.

The increasingly complex mechanism of HMG-CoA reductase.

Haines BE, Wiest O, Stauffacher CV.

Acc Chem Res. 2013 Nov 19;46(11):2416-26. doi: 10.1021/ar3003267. Epub 2013 Jul 30. Review.

Supplemental Content

Support Center